Brief: Lipidor Signs Agreement For Clinical Phase III Study

Lipidor AB

20/09/2023 13:58

Sept 20 (Reuters) - Lipidor AB  LIPI.ST :
    * LIPIDOR SIGNS AGREEMENT FOR CLINICAL PHASE III STUDY
    * SIGNED AN AGREEMENT WITH CLIANTHA RESEARCH TO CONDUCT A
PHASE
III STUDY WITH DRUG CANDIDATE AKP02G2, FOR TREATMENT OF
PSORIASIS
    * STUDY IS EXPECTED TO BEGIN RECRUITMENT OF PATIENTS IN
FIRST HALF
OF 2024
    * HOPES TO BE ABLE TO PRESENT STUDY RESULTS ALREADY IN
DECEMBER OF
SAME YEAR

Source text for Eikon:  ID:nMFN7pW79H 
Further company coverage:  LIPI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))